Association of AGTR1 and ACACB Gene Polymorphism and Diabetic Nephropathy in Type 2 Diabetes
|ClinicalTrials.gov Identifier: NCT01069549|
Recruitment Status : Completed
First Posted : February 17, 2010
Last Update Posted : October 26, 2015
|Condition or disease|
|Diabetes Mellitus, Type 2|
|Study Type :||Observational|
|Actual Enrollment :||476 participants|
|Observational Model:||Case Control|
|Official Title:||Study of the Association of AGTR1 and ACACB Gene Polymorphism and Susceptibility of Diabetic Nephropathy in North Indian Type 2 Diabetic Patients|
|Study Start Date :||November 2009|
|Actual Primary Completion Date :||April 2011|
|Actual Study Completion Date :||May 2011|
subjects with diabetic nephropathy.
Subjects with Type 2 Diabetes. Duration of diabetes should be more than or equal to 5 years. Age between 30 and 85 years. Diabetic nephropathy as defined by ADA.
Subject must be of north Indian origin.
Type 1 diabetes and kidney disease other than diabetes nephropathy are excluded form the study.
Subjects without Diabetic nephropathy.
This group of subject with similar characteristics as group 1 without any evidence of nephropathy.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01069549
|Postgraduate Institute of Medical Education & Research|
|Chandigarh, India, 1610012|
|Study Chair:||anil Bhansali, DM||Postgradute Institute of Medical Education & Research|